Treatment of Respiratory Complications Associated With COVID-19 Infection Using Wharton's Jelly (WJ)-Umbilical Cord (UC) Mesenchymal Stromal Cells (ProTrans): a Randomized Phase II Controlled Clinical Trial
Latest Information Update: 28 Jun 2023
At a glance
- Drugs Mesenchymal-stem-cell-therapy NextCell-Pharma (Primary) ; Dexamethasone
- Indications COVID-19 pneumonia
- Focus Therapeutic Use
- Acronyms ProTrans19+
- 16 Jun 2023 Status changed from recruiting to discontinued.
- 17 Mar 2023 Planned End Date changed from 30 Jul 2022 to 30 Jan 2024.
- 17 Mar 2023 Planned primary completion date changed from 30 Jun 2022 to 31 Dec 2023.